TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study

Relation between Therapy for Hyperthyroidism and the Course of Graves' Ophthalmopathy

Bartalena, L., Marcocci, C., Bogazzi, F., Manetti, L., Tanda, M. L., Dell'Unto, E., Bruno-Bossio, G., Nardi, M., Bartolomei, M. P., Lepri, A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380201 · Cited by 715

Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism

Tallstedt, L., Lundell, G., Tørring, O., Wallin, G., Ljunggren, J.-G., Blomgren, H., & Taube, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262603 · Cited by 521

Epidemiology and Prevention of Graves' Ophthalmopathy

Wiersinga, W. M., & Bartalena, L. (2002) · Thyroid · doi:10.1089/105072502761016476 · Cited by 457

Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy

Gerding, M. N., Meer, J. W. C. V. D., Broenink, M., Bakker, O., Wiersinga, W. M., & Prummel, M. F. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.00959.x · Cited by 328

Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group

Törring, O., Tallstedt, L., Wallin, G., Lundell, G. E. F., Ljunggren, J. ‐., Taube, A., Sääf, M., & Hamberger, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768863 · Cited by 311

Carbimazole and the Autoimmune Response in Graves' Disease

McGregor, A. M., Petersen, M. M., McLachlan, S. M., Rooke, P., Smith, B. R., & Hall, R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008073030603 · Cited by 274

Thyrotropin receptor-associated diseases: from adenomata to Graves disease

Davies, T. F. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26031 · Cited by 260

Pretibial Myxedema

Fatourechi, V. (2005) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200506050-00003 · Cited by 207

Hyperthyroidism in Children Treated with Long Term Medical Therapy: Twenty-Five Percent Remission Every Two Years*

LIPPE, B. M., LANDAW, E. M., & KAPLAN, S. A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1241 · Cited by 192

Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association

Laurberg, P., Nygaard, B., Glinoer, D., Grussendorf, M., & Orgiazzi, J. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390584 · Cited by 191

Thyroid Peroxidase (TPO) and Thyroid Stimulating Hormone Receptor (TSHR) Based Detection on Grave for Pregnant Women

Aulanni’am, A., Zulkarnain, Z., Soeatmadji, D. W., Wuragil, D. K., & Oktanella, Y. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96509 · Cited by 2

Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study

Bezdíčka, M., Kleiblová, P., Soucek, J., Borecká, M., El‐Lababidi, E., Smrž, D., Rataj, M., Šumnı́k, Z., Malíková, J., & Souček, O. (2021) · HORMONES · doi:10.1007/s42000-021-00299-x · Cited by 2

Antithyroid Drug Therapy in Patients with Graves’ Disease

Laurberg, P., & Cooper, D. S. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_6 · Cited by 2

Graves’ Disease and Toxic Nodular Goiter (Plummer’s Disease)

Barczyński, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_3 · Cited by 2

Thyroid and Parathyroid Diseases in Pregnancy

Mestman, J. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00040-5 · Cited by 2

Thyroid and Parathyroid Diseases in Pregnancy

Mestman, J. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00042-1 · Cited by 2

Interdisziplinäre Therapie der Erkrankungen der Orbita

Eckstein, A. K., & Welkoborsky, H. (2024) · Laryngo-Rhino-Otologie · doi:10.1055/a-2216-8879 · Cited by 2

Stress-Triggered Graves’ Disease with Multiple Exacerbations in a Pregnant Woman with High Levels of Thyrotropin Receptor Antibodies and No Complicated Delivery: a Case Report

Bari, F. D., Perelli, S., Scilipoti, A., Wasniewska, M. G., Vita, R., Vermiglio, F., Benvenga, S., & Moleti, M. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00247-7 · Cited by 2

Radioiodine Therapy of Hyperthyroidism in Graves’ Disease

Wong, W. Y., & Goh, A. S. W. (2012) · Medical radiology · doi:10.1007/174_2012_674 · Cited by 2

High maternal serum thyroid-stimulating hormone receptor antibodies with fetal and neonatal thyrotoxicosis after total thyroidectomy for Graves’ disease

Mamah, J. E., Law, H., Prince, S., & Bodmer, C. W. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-264047 · Cited by 1

Regional Differences in the Management of Thyroid Eye Disease: Results from an International Clinical Practice Survey of Endocrinologists

Villagelin, D., Cooper, D. S., & Burch, H. B. (2025) · Thyroid · doi:10.1089/thy.2024.0759 · Cited by 1

Surgical considerations for adult Graves’ disease: a narrative review of indications, perioperative challenges and postoperative outcomes

Bartalena, L., Gallo, D., Piantanida, E., & Tanda, M. L. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2676876 · Cited by 1

Autoimmune thyroid diseases: Peculiarities in pediatric age

Pepe, G., Tropeano, A., Casto, C., Pomi, A. L., & Wasniewska, M. G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824466-1.00004-2 · Cited by 1

Endokrine Orbitopathie

Eckstein, A. K., Oeverhaus, M., Möller, L. C., & Führer‐Sakel, D. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-65929-8_108-1 · Cited by 1

Evaluation of the clinical results of thyroidectomy and RAI treatment in the permanent treatment of Graves' disease

Akbarov, A., Karatay, E., Javadov, M., İlhan, H. D., Boz, A., & Arıcı, C. (2024) · Polish Journal of Surgery · doi:10.5604/01.3001.0054.8003 · Cited by 1

Pediatric Graves’ orbitopathy: TRAb and FT-3 are also prognostic factors in children—A tertiary center study

Al-Ghazzawi, K., Oeverhaus, M., Rama, A., Kiewert, C., Bechrakis, N. E., Chen, Y., Neumann, I., & Eckstein, A. K. (2026) · Thyroid Research · doi:10.1186/s13044-026-00286-7 · Cited by 1

Endocrinologic management of hyperthyroidism and the impact on thyroid eye disease

Rajaii, F., Gupta, S., & Douglas, R. S. (2014) · Taiwan Journal of Ophthalmology · doi:10.1016/j.tjo.2014.03.001 · Cited by 1

Serum TSH Receptor Antibodies Fall Gradually and Only Rarely Switch Functional Activity in Treated Graves’ Disease

Samuels, M. H. (2019) · Clinical Thyroidology · doi:10.1089/ct.2019;31.330-332 · Cited by 1

Radioiodine Treatment of Hyperthyroidism

Luster, M., & Laßmann, M. (2022) · doi:10.1093/med/9780198870197.003.0060 · Cited by 1

Diagnosis and Treatment of Acute Pleural Effusion following Radioiodine Remnant Ablation Post Lobectomy for Thyroid Cancer

Qiu, X., Wang, P., Sa, R., Cheng, L., Jin, Y., Song, H.-J., & Chen, L. (2022) · Diagnostics · doi:10.3390/diagnostics12122982 · Cited by 1

Total Thyroidectomy Improves Quality of Life in Children and Adolescents with Graves' Disease

Feldt‐Rasmussen, U., & Hahn, C. H. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.529-532 · Cited by 1

Graves’ Disease: Novel Diagnostic Approaches and Emerging Treatment Options

Agrawal, R., & Ahmad, S. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1007594 · Cited by 1

2025 Korean Thyroid Association Management Guidelines for Radioactive Iodine Therapy in Patients with Hyperthyroidism

Kim, K. J., Song, E., Kim, M., Kwon, H., Ku, E. J., Kwon, H. W., Yoon, J. H., Lee, E. K., Lee, W. W., Park, Y. J., et al. (2025) · International Journal of Thyroidology · doi:10.11106/ijt.2025.18.1.65 · Cited by 1

Graves’ Disease and Pregnancy

Stagnaro‐Green, A. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_12 · Cited by 1

Complications of Hyperthyroidism

Sayın, İ., Ertek, S., & Cesur, M. (2014) · InTech eBooks · doi:10.5772/58196 · Cited by 2

Interferon‐gamma ELISPOT detecting reactivity of T cells to TSH receptor peptides in G raves' disease

Côté‐Bigras, S., Dionne, A., Asselin‐Mullen, P., Leblicq, C., & Rottembourg, D. (2013) · Clinical Endocrinology · doi:10.1111/cen.12257 · Cited by 1

Treatment of relapsed hyperthyroidism

Chung, J. H. (2018) · Journal of Korean Medical Association · doi:10.5124/jkma.2018.61.4.248 · Cited by 1

Pretibial myxedema: Paradoxical manifestation of thyroid dermopathy after I-131 ablation therapy

Hung, C., Lin, B.-S., & Chen, Y. (2020) · Journal of Medical Sciences · doi:10.4103/1011-4564.280016 · Cited by 1

Cardiovascular risk factors, autoimmunity and insulin resistance in Graves' disease

Ferreira, C., Neves, C., Neves, J. S., Oliveira, S. C., Sokhatska, O., Pereira, M. F., Oliveira, A., Medina, J. L., Delgado, L., & Carvalho, D. M. (2020) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ao190010 · Cited by 1

Hyperthyroidism and Its Implications for Diagnosis and Management of Complications During Pregnancy

Kausar, F. (2020) · BioScientific Review · doi:10.32350/bsr.0201.05 · Cited by 1

Alternating Hyperthyroidism and Hypothyroidism in Graves’ Disease: A Case Report and Literature Review

Alhajjaj, A. H., Al-Said, M. M., & Alkhatam, A. H. (2020) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2020.912050 · Cited by 1

Graves’ Ophthalmopathy

Bartalena, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_23 · Cited by 1

Thyrotoxicosis

Eisenberg, A., Herbst, R., & Setji, T. L. (2018) · Springer eBooks · doi:10.1007/978-3-319-99079-8_3 · Cited by 1

Highlights of the Guidelines on the Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Medeiros-Neto, G. A., Romaldini, J. H., & Abalovich, M. (2011) · Thyroid · doi:10.1089/thy.2011.2106.ed2 · Cited by 1

Hyperthyroidism : Incidence and long term quality-of-life

Abraham‐Nordling, M. (2008) · Figshare · Cited by 1

Annals of Thyroid Research

(2018) · doi:10.26420/annals-thyroid-res · Cited by 1

Thyroid Autoimmunity

Feldt‐Rasmussen, U., Bliddal, S., & Nielsen, C. H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.96017-3 · Cited by 1

Management of Hyperthyroidism in the Setting of Thyroid Eye Disease

Rajaii, F., Gupta, S., & Douglas, R. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1746-4_4

Graves Ophthalmopathy: ContinuingQuest in Search of Initiating Factors and New Therapies

Fatourechi, V. (2008) · Endocrine Practice · doi:10.4158/ep.14.4.412

Bloqueo del eje renina-angiotensina-aldosterona en la enfermedad de Graves

García, J. L. C., Etayo, B. Z., & Calvo, J. (2009) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(09)72716-0

Second-Generation TBBI Assay Assesses the Risk of Fetal/Neonatal Hyperthyroidism in Women with Graves’ Disease

Mestman, J. H. (2014) · Clinical Thyroidology · doi:10.1089/ct.2014;26.316-318

Risque d’ophtalmopathie et iode 131 : comment préparer les patients ?

Duron, F. (2009) · Médecine Nucléaire · doi:10.1016/j.mednuc.2009.02.007

Infertilités endocriniennes féminines en dehors du syndrome des ovaires polykystiques

Chabbert‐Buffet, N. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0061-5_16

Should the Approach to Management of Graves' Hyperthyroidism in Women of Child-Bearing Age Be Revised?

Mestman, J. H. (2013)

Natural History, Risk Factors, and Management of Patients with Mild GO

Stan, M. N. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_18

Változások a pajzsmirigybetegségek radiojódkezelésében

Konrády, A. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30322

Neonatal Graves-Basedow disease due to long-standing TRAb persistence following total thyroidectomy

Dragomir-Ananie, E. T., Procopiuc, C., Caliopsia, F., Gusa, M., & Diaconu, C. C. (2015) · Journal of Translational Medicine and Research · doi:10.21614/jtmr-20-3-51

Fetal Medical Therapy

Speiser, P., & Milunsky, A. (2015) · Wiley eBooks · doi:10.1002/9781118981559.ch27

Hyperthyreose

Schott, M. (2013) · CME · doi:10.1007/s11298-013-0361-3

Autoimmune Thyroid Disease and Refractory Chronic Urticaria: Thyroidectomy as a Treatment for Long Standing Remission. A Case Report

Francés, C., Nicolau, J., Garcia, M., Nadal, C., Gómez, L., & Masmiquel, L. (2014) · Experimental and Clinical Endocrinology & Diabetes Reports · doi:10.1055/s-0034-1389902

1. Treatment of Graves' Disease with Antithyroid Drugs.

Tagami, T. (2010) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.99.733

Radioactive Iodine Therapy and Thyroid Eye Disease From an Ophthalmologist’s Perspective

Choi, C. J., Gilbert, A. L., & Lee, N. G. (2015) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000079

Sorgen Sie für ein gesundes Mittelmaß!

Schott, M. (2014) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-014-2543-7

The patient with thyroid disease

Visser, W. E. (2008) · CRC Press eBooks · doi:10.3109/9780203092200-11

Pregnancy and Hyperthyroidism

Sheikh, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_18

Fetal Thyroid and Adrenal Disease

Robson, S. C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5908-0.00021-1

Conversión a hipotiroidismo en tratamiento con I131* por hipertiroidismo secundario a enfermedad de graves: Hospital de San José, Enero 2005 - Diciembre 2008

Cadavid, L., Vivas, J. J., & Lombo, R. A. M. (2009) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.v18.n4.2009.559

Prise en charge des dysthyroïdies pendant la grossesse et le post-partum

Bars, F. P. (2015) · Vocation Sage-femme · doi:10.1016/j.vsf.2015.06.008

Thyroid Peroxidase Antibodies in Non-Autoimmune Hyperthyroidism Treated with Radioactive Iodine

Listewnik, M. H., Listewnik, M. H., Miazgowski, T., Jaskólska, K., Jasiakiewicz, K., & Birkenfeld, B. (2016) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-113124

Autoanticorps des maladies auto-immunes de la thyroïde. Indications des dosages

Massart, C., & D’Herbomez, M. (2013) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(13)59534-3

Radioiodine Therapy of Benign Thyroid Diseases

Campennì, A., Deandreis, D., Finessi, M., Ruggeri, R. M., & Baldari, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-17494-1_2

utcome of Graves’ Disease Treated with Anti-Thyroid Drugs and Time Courses of Anti-Tsh Receptor Antibodies

Yamamoto, T. (2019) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.155

Updates of Radioiodine Treatment for Graves' Disease

Jeong, S. Y. (2019) · International Journal of Thyroidology · doi:10.11106/ijt.2019.12.2.85

Graves’ Disease treatment with radioiodine (131I) 10 mCi: clinical experience of a central hospital

Martins, A., Osório, A., Gomes, V., Vaz, R., Cantinho, G., & Bugalho, M. J. (2019) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ao180065

Thyroid Disease

Weetman, A. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00040-x

Comparative Safety of Therapies for Hyperthyroidism Planning Pregnancy: A Network Meta-analysisPreprint

Fang, X., Huang, H., Lin, W., Liang, J., Wen, J., & Chen, G. (2020) · medRxiv · doi:10.1101/2020.05.11.20097774

Management of hyperthyroid patients following radioactive iodine therapy, with a specific emphasis on Graves’ disease

Taïeb, D. (2020) · Médecine Nucléaire · doi:10.1016/j.mednuc.2020.06.003

Pregnancy and Graves’ Disease

Panaitescu, A. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96245

Molecular Mechanisms of Graves' Ophthalmopathy. A focus on smoking and radioiodine.

Shahida, B. (2021) · Lund University Publications (Lund University)

A Comparative Study between Different Therapeutic Modalities for the Management of Patients with Graves' Disease

Elshorbagy, E., Khalifa, N. A., Zawia, M. E. H. M., & Awad, M. M. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.185512

Thyroid-Stimulating Hormone Receptor Antibodies in Refractory Graves’ Disease Change Differently According to the Type of Definitive Therapy Administered

Feldt‐Rasmussen, U. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.350-353

Antithyroid drug therapy for Graves’ disease

Shin, S. M., & Yi, K. H. (2021) · Journal of Korean Medical Association · doi:10.5124/jkma.2021.64.10.690

Shared parenting: mothers' experiences : "Experiences of mothering: how mothers view their roles in shared care arrangements for children following relationship separation"

Riwhi, J. (2010) · Otago University Research Archive (University of Otago)

Graves’ Hyperthyroidism in Pregnancy

Nguyen, C. T., & Mestman, J. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00023-5

Graves’ ophthalmopathy and dermopathy

Wiersinga, W. M. (2011) · doi:10.1093/med/9780199235292.003.3205

Vitamina D em doenças tireoidianas autoimunes e relação com perfil hormonal tireoidiano e atividade inflamatória de células Th1, Th2 e Th17

Botelho, I. M. B. (2018) · doi:10.47749/t/unicamp.2018.1063361

Predictive Value of TRAb in the Early Drug Treatment of GD

陶, 玥. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.1112862

Management of Graves’ Hyperthyroidism

Orgiazzi, J. (2022) · doi:10.1093/med/9780198870197.003.0062

Epidemiology of Thyroid Eye Disease

Ramesh, S. (2022) · Springer eBooks · doi:10.1007/978-3-030-92794-3_43

Graves’ Orbitopathy and Dermopathy

Wiersinga, W. M. (2022) · doi:10.1093/med/9780198870197.003.0063

Management of Thyroid Disorders Before Assisted and Spontaneous Pregnancies

Poppe, K. G., Veltri, F., & Unuane, D. (2022) · doi:10.1093/med/9780198870197.003.0171

Graves’ Disease

Chng, C. L. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_2

The Prognostic Value of Thyroid Stimulating Immunoglobulin in the Management of Graves’ DiseasePreprint

Chen, X., Zhou, Y., Zhou, M., Qi, Y., Wang, W., Ning, G., & Wang, S. (2020) · doi:10.21203/rs.3.rs-26936/v1

Thyroid Eye Disease

Godfrey, K. J., & Kazim, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-61329-3.00018-4 · Cited by 1

Radio-iodine treatment of hyperthyroidism

Luster, M., & Laßmann, M. (2011) · doi:10.1093/med/9780199235292.003.3196

Management of Graves’ hyperthyroidism

Orgiazzi, J., & Bournaud, C. (2011) · doi:10.1093/med/9780199235292.003.3202

The patient with thyroid disease

Visser, W. E. (2008) · Reproductive medicine and assisted reproductive techniques series · doi:10.3109/9780203092200.008

Ipertiroidismo

Proust-Lemoine, E., & Wémeau, J.-L. (2018) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(18)91702-x

Hipertiroidismo

Proust-Lemoine, E., & Wémeau, J.-L. (2018) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(18)91423-6

Factors affecting the course of Graves’ Orbitopathy and poor response to glucocorticoid treatment followed by orbital radiotherapy.

Jagiełło-Korzeniowska, A., Sokołowski, A., Hubalewska–Dydejczyk, A., Romanowska‐Dixon, B., & Bałdys‐Waligórska, A. (2022) · OphthaTherapy Therapies in Ophthalmology · doi:10.24292/01.ot.190522

Radionuclide Therapy in Benign Thyroid Diseases: Graves’ Disease

Araz, M., & Özkan, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-97220-2_5

Radioiodine Therapy of Anti-TPO Positive Patients with Graves’ Disease Is Associated with Early Hypothyroidism

Feldt‐Rasmussen, U. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.336-338

Management of fetal hyperthyroidism caused by persistent autoimmune antibodies in a case of previously treated maternal Graves’ disease

Karri, S. R., Roy, P. S., Nandi, N., Shenoy, V. V., & Watson, D. (2022) · Obstetric Medicine · doi:10.1177/1753495x221146340

Prevención, diagnóstico y manejo de las complicaciones en pacientes oncológicos: un enfoque multidisciplinario

del Azuay, U., Jerves-Andrade, M., Ruilova-González, L., del Azuay, U., Duque, G., & del Azuay, U. (2022) · doi:10.33324/ceuazuay.227

Systemic Thyroid Dysfunction in Graves Disease

Kamimoto, J. J., & Flood, J. J. (2023) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000463

Treatment of Graves’ Disease in Pregnancy Requires Multiple Considerations

Bliddal, S., & Feldt‐Rasmussen, U. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.139-141

Manejo de la enfermedad tiroídea en el embarazo y puerperio

Paula Vergara, U., Verónica Araya, Q., Sepúlveda-Martínez, Á., & Parra-Cordero, M. (2019) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2019.70053

Graves’ Eye Disease

Agarwal, A. K., Fernando, R., Parameswaran, R., Mishra, A., & Pradhan, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-0938-4_55

Evaluation of Aqueous Flare in Graves’ Ophthalmopathy and its Relationship with Thyroid Hormones, Antibodies, and Clinical Activity Score

Topçu, H. (2023) · Beyoglu Eye Journal · doi:10.14744/bej.2023.80557

Painless thyroiditis as a precursor to the relapse of Graves’ disease during remission

Iwaku, K., Noh, J. Y., Watanabe, N., Sugino, K., & Ito, K. (2023) · Thyroid Science · doi:10.1016/j.thscie.2023.100003

Effect of radioiodine treatment for Graves’ disease on the generation of TSH anti-receptor stimulating antibodies (TSI)

Fiorin, L. B., Kasamatsu, T. S., Camacho, C. P., Furuzawa, G. K., Leite, M. F. L., Castiglioni, M. L. V., Matsumura, L. K., Furlanetto, R. P., Batista, M. C., Maciel, R. M. B., et al. (2025) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2025-0085

Remission Rate of Graves' Disease and the Trend of Changes in Serum TSH Receptor Antibodies in Prolonged Antithyroid Drug Treatment

Villagelin, D., dos Santos, R. B., & Romaldini, J. H. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.101473 · Cited by 9

utcome of Graves’ Disease Treated with Anti-Thyroid Drugs and Time Courses of Anti-Tsh Receptor Antibodies

Yamamoto, T. (2019) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.155

In vitro suppression of anti-TSH receptor antibody by autologous anti-idiotypic antibody in patients with Graves' disease.

Balázs, C., & Molnár, I. (1995) · PubMed · Cited by 3

Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients

Tamai, H., Hayaki, I., Kawai, K., Komaki, G., Matsubayashi, S., Kuma, K., Kumagai, L. F., & Nagataki, S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7744989 · Cited by 52